StockWatch
·
Pharmaceuticals
Regulatory29 May 2026, 06:11 pm

Rubicon Research Extends IPO Proceeds Use to March 2027

AI Summary

Rubicon Research Ltd's board approved extending the timeline for utilizing unutilized IPO proceeds by one year, up to March 31, 2027. As of March 31, 2026, ₹3,236.46 Million of the ₹4,712.74 Million raised in the IPO had been utilized. The remaining ₹1,476.28 Million deployment is deferred due to ongoing debt repayment discussions, strategic investment vetting, and dynamic management of general corporate purposes. There is no change in the objects of the issue.

Key Highlights

  • Rubicon Research extends IPO proceeds utilization timeline to March 31, 2027.
  • ₹1,476.28 Million of IPO proceeds remain unutilized as of March 31, 2026.
  • Deployment deferred due to debt repayment talks, investment vetting, and operational needs.
  • No change in the original objects of the IPO issue.
  • Deviation/variation statement for IPO proceeds utilization filed for quarter ended March 31, 2026.